What was the primary endpoint of the Effasayil trial? Featuring Brad Glick, DO, MPH | Program Director, Dermatology ResidencyLarkin Community Hospital Palm Springs CampusHialeah, FL | Published September 01, 2023View video transcriptLoading...Related MediaPowered by Polaris TM